https://www.studyops.com/portfolio-items/donec-ornare-turpis-eget/portfolio_1/ 2013-10-14T15:47:29+00:00 https://www.studyops.com/portfolio-items/donec-ornare-turpis-eget/portfolio_2/ 2013-10-14T15:47:30+00:00 https://www.studyops.com/portfolio-items/mauris-fringilla-voluts/portfolio_3/ 2013-10-14T15:56:29+00:00 https://www.studyops.com/portfolio-items/proin-sodales-quam/portfolio_4/ 2013-10-14T16:11:59+00:00 https://www.studyops.com/portfolio-items/suspendisse-pharetra-urna/portfolio_5/ 2013-10-14T16:22:36+00:00 https://www.studyops.com/?attachment_id=4053 2013-10-14T18:33:09+00:00 https://www.studyops.com/?attachment_id=4054 2013-10-14T18:33:10+00:00 https://www.studyops.com/?attachment_id=10904 2014-11-06T21:48:53+00:00 https://www.studyops.com/studyops-one-page1/felsot_gs/ 2014-11-11T00:41:34+00:00 https://www.studyops.com/studyops-one-page1/szimm_gs/ 2014-11-11T00:41:35+00:00 https://www.studyops.com/studyops-one-page1/3m/ 2014-11-12T00:05:59+00:00 https://www.studyops.com/studyops-one-page1/ag/ 2014-11-12T00:06:01+00:00 https://www.studyops.com/studyops-one-page1/amgen/ 2014-11-12T00:06:02+00:00 https://www.studyops.com/studyops-one-page1/astrzenica/ 2014-11-12T00:06:03+00:00 https://www.studyops.com/studyops-one-page1/endo/ 2014-11-12T00:06:10+00:00 https://www.studyops.com/studyops-one-page1/forest/ 2014-11-12T00:06:11+00:00 https://www.studyops.com/studyops-one-page1/bl/ 2014-11-12T00:16:45+00:00 https://www.studyops.com/studyops-one-page1/baxter/ 2014-11-12T00:17:28+00:00 https://www.studyops.com/studyops-one-page1/bayer/ 2014-11-12T00:18:01+00:00 https://www.studyops.com/studyops-one-page1/biogen/ 2014-11-12T00:18:34+00:00 https://www.studyops.com/studyops-one-page1/bms/ 2014-11-12T00:20:25+00:00 https://www.studyops.com/studyops-one-page1/cephalon/ 2014-11-12T00:20:59+00:00 https://www.studyops.com/studyops-one-page1/endo-2/ 2014-11-12T00:21:23+00:00 https://www.studyops.com/studyops-one-page1/forest-2/ 2014-11-12T02:25:35+00:00 https://www.studyops.com/studyops-one-page1/genzyme/ 2014-11-12T02:35:59+00:00 https://www.studyops.com/studyops-one-page1/gilead/ 2014-11-12T02:36:00+00:00 https://www.studyops.com/studyops-one-page1/gsk/ 2014-11-12T02:36:01+00:00 https://www.studyops.com/studyops-one-page1/icon/ 2014-11-12T02:36:01+00:00 https://www.studyops.com/studyops-one-page1/jj/ 2014-11-12T03:13:54+00:00 https://www.studyops.com/studyops-one-page1/kendle/ 2014-11-12T03:14:24+00:00 https://www.studyops.com/studyops-one-page1/lilly/ 2014-11-12T03:14:46+00:00 https://www.studyops.com/studyops-one-page1/merck/ 2014-11-12T03:15:08+00:00 https://www.studyops.com/studyops-one-page1/mylan/ 2014-11-12T03:15:49+00:00 https://www.studyops.com/studyops-one-page1/abbvie/ 2014-11-12T03:35:58+00:00 https://www.studyops.com/studyops-one-page1/bionor/ 2014-11-12T03:40:29+00:00 https://www.studyops.com/studyops-one-page1/calimmune/ 2014-11-12T03:44:58+00:00 https://www.studyops.com/studyops-one-page1/geovax/ 2014-11-12T03:52:36+00:00 https://www.studyops.com/studyops-one-page1/novo/ 2014-11-12T03:55:11+00:00 https://www.studyops.com/studyops-one-page1/parexel/ 2014-11-12T03:55:58+00:00 https://www.studyops.com/studyops-one-page1/pfizer/ 2014-11-12T03:56:36+00:00 https://www.studyops.com/studyops-one-page1/pg/ 2014-11-12T03:57:10+00:00 https://www.studyops.com/studyops-one-page1/pra/ 2014-11-12T03:58:22+00:00 https://www.studyops.com/studyops-one-page1/purdue/ 2014-11-12T03:59:11+00:00 https://www.studyops.com/studyops-one-page1/quintiles/ 2014-11-12T03:59:56+00:00 https://www.studyops.com/studyops-one-page1/rb/ 2014-11-12T04:02:31+00:00 https://www.studyops.com/studyops-one-page1/roche/ 2014-11-12T04:03:15+00:00 https://www.studyops.com/studyops-one-page1/sanofi/ 2014-11-12T04:03:50+00:00 https://www.studyops.com/studyops-one-page1/vertex/ 2014-11-12T04:04:23+00:00 https://www.studyops.com/studyops-one-page1/inc/ 2014-11-12T04:08:00+00:00 https://www.studyops.com/studyops-one-page1/blackledge_gs/ 2014-11-13T19:03:14+00:00 https://www.studyops.com/studyops-one-page1/blackledge/ 2014-11-13T19:15:40+00:00 https://www.studyops.com/studyops-one-page1/bokarius_gs_2/ 2014-11-13T19:21:20+00:00 https://www.studyops.com/studyops-one-page1/hassler_gs_2/ 2014-11-13T19:25:45+00:00 https://www.studyops.com/studyops-one-page1/ngo_gs/ 2014-11-13T19:28:16+00:00 https://www.studyops.com/studyops-one-page1/zaphiris_gs/ 2014-11-13T19:29:38+00:00 https://www.studyops.com/studyops-one-page1/granik_gs/ 2014-11-13T19:31:53+00:00 https://www.studyops.com/studyops-one-page1/mccloud_gs/ 2014-11-13T19:54:27+00:00 https://www.studyops.com/studyops-one-page1/paul_gs/ 2014-11-13T19:58:55+00:00 https://www.studyops.com/?attachment_id=11308 2014-11-13T22:52:28+00:00 https://www.studyops.com/?attachment_id=11309 2014-11-13T22:55:37+00:00 https://www.studyops.com/?attachment_id=11452 2014-11-15T18:39:47+00:00 https://www.studyops.com/?attachment_id=11454 2014-11-15T18:41:42+00:00 https://www.studyops.com/?attachment_id=11455 2014-11-15T18:51:38+00:00 https://www.studyops.com/?attachment_id=11457 2014-11-15T18:53:26+00:00 https://www.studyops.com/?attachment_id=11460 2014-11-15T19:07:59+00:00 https://www.studyops.com/?attachment_id=11461 2014-11-15T19:10:37+00:00 https://www.studyops.com/studyops-one-page1/ipad_slider_3/ 2014-11-15T20:00:46+00:00 https://www.studyops.com/studyops-one-page1/consult_slider_3/ 2014-11-15T20:01:37+00:00 https://www.studyops.com/studyops-one-page1/sondra/ 2014-11-15T20:34:34+00:00 https://www.studyops.com/11627-2/paul/ 2014-11-19T21:58:22+00:00 https://www.studyops.com/merck-drug-works-vytorin-study-proves-successful/screen-shot-2014-11-20-at-10-32-33-am/ 2014-11-20T18:34:45+00:00 https://www.studyops.com/world-drug-bill-will-reach-1-3-trillion-by-2018/screen-shot-2014-11-20-at-2-16-31-pm/ 2014-11-20T22:17:04+00:00 https://www.studyops.com/10-million-child-deaths-attributed-to-a-lack-of-toilets/screen-shot-2014-11-20-at-2-33-02-pm/ 2014-11-20T22:33:26+00:00 https://www.studyops.com/studyops-awarded-fibromyalgia-clinical-trial-screening-will-begin-in-december/fibro/ 2014-11-26T16:20:08+00:00 https://www.studyops.com/should-the-fda-force-drug-makers-to-discuss-their-clinical-trials/fda-approved/ 2014-12-01T19:07:51+00:00 https://www.studyops.com/groundbreaking-research-is-uncovering-better-ways-to-keep-aids-at-bay/n-hiv-large570/ 2014-12-02T18:08:01+00:00 https://www.studyops.com/otsuka-expands-in-neurologic-diseases-with-deal-to-buy-avanir-for-3-5-billion/avanir/ 2014-12-02T19:43:33+00:00 https://www.studyops.com/studyops-is-aggressively-recruiting-rheumatologist-principal-investigators-for-ra-trials/ra/ 2014-12-03T17:56:10+00:00 https://www.studyops.com/the-debate-over-the-cost-to-develop-a-new-drug/drugs/ 2014-12-03T19:50:06+00:00 https://www.studyops.com/puma-biotech-delays-breast-cancer-drug-filing-to-fda/puma/ 2014-12-03T20:03:48+00:00 https://www.studyops.com/mylan-receives-tentative-fda-approval/myland/ 2014-12-04T22:03:55+00:00 https://www.studyops.com/fda-acceptance-of-smaller-clinical-trials-offers-upside-to-biotech-stocks/btk/ 2014-12-05T15:30:59+00:00 https://www.studyops.com/the-biotech-index-is-more-than-a-triple-bagger-ramp-since-2010/btk-2/ 2014-12-05T15:45:12+00:00 https://www.studyops.com/merck-acquiring-cubist-focusing-on-hospital-care/cubist/ 2014-12-08T17:31:44+00:00 https://www.studyops.com/pharmas-top-10-ma-deals-of-2014s-first-half/merger-aqusition/ 2014-12-09T17:13:26+00:00 https://www.studyops.com/did-merck-pay-3b-too-much-for-cubist/cubist-2/ 2014-12-09T19:20:55+00:00 https://www.studyops.com/valeant-puts-dealmaking-on-hold-to-focus-on-the-bottom-line/valeant-offers-to-buy-allergan-with-pershings-support/ 2014-12-10T15:47:35+00:00 https://www.studyops.com/crude-oil-getting-decimated-not-another-govt-rescue-please/oil/ 2014-12-10T19:59:12+00:00 https://www.studyops.com/more-pharma-shake-up-takedas-u-s-chief-bows-out/takeda-pharmaceutical-co/ 2014-12-11T17:07:55+00:00 https://www.studyops.com/the-cost-to-develop-a-new-drug-balloons-up-to-2-6b/cost/ 2014-12-11T19:50:19+00:00 https://www.studyops.com/studyops-one-page1/massen/ 2014-12-12T00:41:09+00:00 https://www.studyops.com/teva-sets-2015-sales-forecast-up-to-1b-lower-than-analysts-expected/teva/ 2014-12-14T20:33:38+00:00 https://www.studyops.com/biotech-entrepreneur-tony-coles-takes-aim-at-parkinsons-and-alzheimers/logo-3/ 2014-12-15T17:43:46+00:00 https://www.studyops.com/5-12-year-low-on-crude-oil/wti/ 2014-12-15T21:32:36+00:00 https://www.studyops.com/isis-pharma-bad-name-hot-pipeline-major-ramp-to-new-highs/isis_pharmaceuticals_stock-ai_r620x349/ 2014-12-15T21:43:30+00:00 https://www.studyops.com/russian-stock-exchange-ouch/russia/ 2014-12-16T17:30:37+00:00 https://www.studyops.com/studyops-one-page1/wei/ 2014-12-17T22:16:50+00:00 https://www.studyops.com/studyops-one-page1/wei-2/ 2014-12-18T01:57:31+00:00 https://www.studyops.com/studyops-one-page1/wei-3/ 2014-12-18T22:02:32+00:00 https://www.studyops.com/auspex-pharma-soars-on-huntingtons-disease-drug-trial/auspex/ 2014-12-19T00:02:40+00:00 https://www.studyops.com/auspex-pharma-soars-on-huntingtons-disease-drug-trial/aspx/ 2014-12-19T00:04:41+00:00 https://www.studyops.com/auspex-pharma-soars-on-huntingtons-disease-drug-trial/auspex-2/ 2014-12-19T00:05:02+00:00 https://www.studyops.com/auspex-pharma-soars-on-huntingtons-disease-drug-trial/auspex-3/ 2014-12-19T00:05:52+00:00 https://www.studyops.com/pfizer-turns-the-sex-talk-toward-50-ish-women-with-menopause-awareness-push/natural-menopause-treatments4/ 2014-12-22T21:42:06+00:00 https://www.studyops.com/the-top-10-patent-losses-of-2015/patent/ 2014-12-28T21:28:07+00:00 https://www.studyops.com/opko-health-opk-just-signed-a-worldwide-partnership-deal-with-pfizer-receives-295-million/opk/ 2014-12-28T21:39:46+00:00 https://www.studyops.com/gsk-ready-to-ax-hundreds-in-u-s-as-advair-sales-plummet/gsk-2/ 2014-12-29T18:37:57+00:00 https://www.studyops.com/salix-ceo-takes-a-hike-in-latest-fallout-from-inventory-snafu/salix/ 2015-01-06T17:59:42+00:00 https://www.studyops.com/crude-oil-closes-at-48-01-down-50-from-august/oil06jan15/ 2015-01-07T01:03:06+00:00 https://www.studyops.com/cancer-fighting-cytomx-lands-20-million-pfizer-investment-makes-key-hires/cytomx/ 2015-01-07T18:53:58+00:00 https://www.studyops.com/increases-in-womens-clinical-trial-participation-bring-uneven-gains/ct-woms/ 2015-01-08T21:23:20+00:00 https://www.studyops.com/an-upside-break-of-554-on-the-pharma-index-means-off-to-the-races-again/drg554/ 2015-01-08T21:28:17+00:00 https://www.studyops.com/hedge-fund-exec-aims-new-legal-weapon-at-big-pharmas-evergreened-patents/kyle-bass-hedge-fund-has-taken-a-stake-in-general-motors/ 2015-01-09T16:54:29+00:00 https://www.studyops.com/gilead-buying-vertex-among-bold-biotech-stock-predictions-for-2015/vrtx/ 2015-01-09T17:01:11+00:00 https://www.studyops.com/shire-to-buy-biopharma-company-nps-pharma-for-5-2-billion-up-80-from-october/npsp/ 2015-01-12T19:56:34+00:00 https://www.studyops.com/studyops-one-page1/bokarius_photo_gs/ 2015-01-14T01:46:04+00:00 https://www.studyops.com/studyops-one-page1/zaphiris_gs-2/ 2015-01-14T01:48:37+00:00 https://www.studyops.com/studyops-one-page1/sondra-2/ 2015-01-14T02:08:27+00:00 https://www.studyops.com/studyops-one-page1/rovetta_denae_photo_gs/ 2015-01-14T02:45:40+00:00 https://www.studyops.com/stocks-and-commodities-head-south-holiday-sales-failed-pharma-holds-tight/indu_weekly_14jan/ 2015-01-14T16:14:18+00:00 https://www.studyops.com/novartis-pharmaceuticals-announces-a-joint-investment-company-with-qualcomm/qcom/ 2015-01-14T16:34:13+00:00 https://www.studyops.com/dont-use-generic-lyrica-for-pain-pfizer-warns-u-k-providers-or-else/pfe/ 2015-01-15T19:41:05+00:00 https://www.studyops.com/swiss-markets-slide-hard-roche-novartis-actelion-and-lonza-shares-plummet/swiss_market/ 2015-01-15T23:11:17+00:00 https://www.studyops.com/jjs-boss-says-pharma-unit-fastest-growing-in-the-drug-business/jnj/ 2015-01-21T00:14:56+00:00 https://www.studyops.com/jjs-boss-says-pharma-unit-fastest-growing-in-the-drug-business/jnj-2/ 2015-01-21T00:19:30+00:00 https://www.studyops.com/merck-pulls-victrelis-in-the-u-s-gilead-and-abbvie-still-rule-hep-c/mrk/ 2015-01-21T18:33:44+00:00 https://www.studyops.com/valeants-move-to-walk-away-from-allergan-bodes-well-for-the-shares/vrx/ 2015-01-22T18:03:40+00:00 https://www.studyops.com/gilead-gild-pharma-101-excellent-management-happy-investors/gild/ 2015-01-23T17:24:55+00:00 https://www.studyops.com/abilify-patent-expiration-sends-bms-top-line-2015-forecast-south/bmy/ 2015-01-27T18:58:28+00:00 https://www.studyops.com/amgen-blows-out-4th-q-with-profits-up-27/amgn/ 2015-01-28T00:28:49+00:00 https://www.studyops.com/gilead-gets-the-united-health-nod-for-hep-c-treatment-harvoni/gild2/ 2015-01-29T18:02:56+00:00 https://www.studyops.com/more-adverse-event-red-tape-from-the-fda-good-or-bad/so-logo-lab-jkt/ 2015-02-03T18:47:48+00:00 https://www.studyops.com/gilead-announces-blow-out-numbers-but-the-shares-fall/gild04feb2015/ 2015-02-04T18:26:58+00:00 https://www.studyops.com/gsk-tees-up-the-viiv-spinoff-again/gsk-3/ 2015-02-04T20:24:11+00:00 https://www.studyops.com/hospira-pops-39-on-pfizers-90-bid/hsp/ 2015-02-05T16:53:56+00:00 https://www.studyops.com/alkermes-ramps-5-on-phase-i-top-line-data/alks/ 2015-02-11T01:50:27+00:00 https://www.studyops.com/rd-for-cns-is-not-dead/rhhby/ 2015-02-11T23:24:20+00:00 https://www.studyops.com/gild-pops-on-insider-1-million-buy-in/gild11feb/ 2015-02-12T01:25:03+00:00 https://www.studyops.com/reading-between-the-lines-is-the-pfizer-boss-thinking-conversion/pfe-2/ 2015-02-12T17:57:49+00:00 https://www.studyops.com/abbvie-shares-on-hold-until-hcv-drug-and-biosimilar-humira-give-visibility/abbv/ 2015-02-17T20:39:45+00:00 https://www.studyops.com/labcorp-takes-down-covance-for-6-1-billion-deal-approved/cvd/ 2015-02-19T19:17:26+00:00 https://www.studyops.com/labcorp-takes-down-covance-for-6-1-billion-deal-approved/q/ 2015-02-19T19:42:01+00:00 https://www.studyops.com/shires-vyvanse-for-binge-eating-disorder-yes-no-maybe/shire/ 2015-02-26T15:32:41+00:00 https://www.studyops.com/kite-spends-21-million-for-t-cell-factory-and-adds-450-million-to-mkt-cap/kite/ 2015-03-20T14:38:35+00:00 https://www.studyops.com/?attachment_id=12235 2019-01-11T20:35:52+00:00